Sotera Health (NASDAQ:SHC) Given Consensus Rating of “Moderate Buy” by Analysts

Sotera Health (NASDAQ:SHC) has been given a consensus rating of “Moderate Buy” by the six research firms that are covering the firm, Marketbeat reports. Two analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 1-year price target among brokers that have covered the stock in the last year is $15.92.

Several equities research analysts have weighed in on the company. The Goldman Sachs Group started coverage on Sotera Health in a report on Friday, December 6th. They issued a “neutral” rating and a $14.00 price target for the company. Barclays lowered their target price on shares of Sotera Health from $17.00 to $16.00 and set an “overweight” rating for the company in a research note on Friday, February 28th.

Sotera Health Stock Performance

Shares of SHC stock opened at $11.90 on Wednesday. The company has a current ratio of 2.88, a quick ratio of 2.61 and a debt-to-equity ratio of 4.91. The company has a market cap of $3.37 billion, a PE ratio of 47.60 and a beta of 1.92. Sotera Health has a 12-month low of $10.71 and a 12-month high of $17.08. The business’s fifty day simple moving average is $12.94 and its 200-day simple moving average is $14.14.

Institutional Investors Weigh In On Sotera Health

Institutional investors and hedge funds have recently modified their holdings of the company. Victory Capital Management Inc. increased its holdings in Sotera Health by 25.7% in the 3rd quarter. Victory Capital Management Inc. now owns 32,610 shares of the company’s stock worth $545,000 after buying an additional 6,666 shares during the period. Mutual of America Capital Management LLC lifted its stake in Sotera Health by 15.9% during the 3rd quarter. Mutual of America Capital Management LLC now owns 82,654 shares of the company’s stock valued at $1,380,000 after acquiring an additional 11,342 shares during the period. Thrivent Financial for Lutherans boosted its holdings in shares of Sotera Health by 19.4% in the 3rd quarter. Thrivent Financial for Lutherans now owns 35,929 shares of the company’s stock valued at $600,000 after acquiring an additional 5,835 shares during the last quarter. Charles Schwab Investment Management Inc. increased its stake in shares of Sotera Health by 18.3% in the third quarter. Charles Schwab Investment Management Inc. now owns 1,348,917 shares of the company’s stock worth $22,527,000 after acquiring an additional 208,914 shares during the period. Finally, Sessa Capital IM L.P. raised its holdings in shares of Sotera Health by 46.5% during the third quarter. Sessa Capital IM L.P. now owns 6,300,597 shares of the company’s stock worth $105,220,000 after purchasing an additional 2,000,000 shares during the last quarter. Institutional investors and hedge funds own 91.03% of the company’s stock.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.